Cerebromikrovaskulære effekter av tidsbegrenset spising hos eldre voksne
25. juni 2026 oppdatert av: University of Oklahoma
Den sentrale hypotesen i denne studien er at tettere overholdelse av tidsbegrenset spising (TRE) vil forbedre endotelfunksjon, nevrovaskulære (NVC) responser, noe som resulterer i forbedret kognitiv ytelse, potensielt gjennom aktivering av SIRT1-avhengige vasoprotektive veier.
Studieoversikt
Status
Fullført
Forhold
Intervensjon / Behandling
Detaljert beskrivelse
Denne hypotesen vil bli testet ved å vurdere effekten av TRE (ikke mer enn 10 timers spisevindu hver dag i 6 måneder) hos friske voksne (≥21 år).
Gruppen av forsøkspersoner som er registrert i TRE-armen vil bli sammenlignet med kontrollgruppen.
Alle deltakerne vil bli randomisert til hver av grenene av studien.
Studietype
Intervensjonell
Registrering (Faktiske)
11
Fase
- Ikke aktuelt
Kontakter og plasseringer
Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.
Studiesteder
-
-
Oklahoma
-
Oklahoma City, Oklahoma, Forente stater, 73117
- University of Oklahoma Health Sciences Center
-
-
Deltakelseskriterier
Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
21 år og eldre (Voksen, Eldre voksen)
Tar imot friske frivillige
Ja
Beskrivelse
Inklusjonskriterier:
-Friske voksne ≥21 år
Ekskluderingskriterier:
- Manglende evne til å lese eller skrive på engelsk
Studieplan
Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Annen
- Tildeling: N/A
- Intervensjonsmodell: Enkeltgruppeoppdrag
- Masking: Ingen (Open Label)
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Eksperimentell: Time restricted eating
14 h of fasting daily (10 h of free eating)
|
14:10 daily fasting regimen
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Neurovascular Coupling Using Functional Near Infrared Spectroscopy (fNIRS)
Tidsramme: Baseline, 6 months
|
Functional near infrared spectroscopy (fNIRS) will be performed during the cognitive n-back task.
fNIRS approach generates data that represent a relative change in oxygenated hemoglobin measured over the cortical brain tissues.
fNIRS data is analyzed using a pipeline based on the General Linear Model (GLM) approach created using the Brain AnalyzIR toolbox and implemented in MatLab.
At the subject level, regression coefficients (beta values) are extracted to characterize individual neurovascular coupling response in the prefrontal cortex across all n-back blocks.
It is expected that more difficult cognitive tasks will lead to increased neurovascular coupling responses in healthy individuals, but no clinically relevant ranges exist for this measure.
|
Baseline, 6 months
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Neurovascular Coupling Using the Dynamic Retinal Vessel Analysis
Tidsramme: Baseline, 6 months
|
Flicker light-induced dilation of the retinal vessels (percentage increase over baseline diameter) will be measured in the right or left eye of each study participant using the Dynamic Vessel Analyzer (DVA, IMEDOS Systems, Jena, Germany).
The change in retinal vessel diameters is tracked and reported as a %change from baseline, before and after treatment.
|
Baseline, 6 months
|
|
Neurovascular Coupling Using Transcranial Doppler
Tidsramme: Baseline, 6 months
|
Transcranial Doppler sonography will be used to measure the change in the blood flow velocities during the cognitive n-back task between before and after treatment.
|
Baseline, 6 months
|
|
Microvascular Endothelial Function
Tidsramme: Baseline, 6 months
|
Changes in microvascular endothelial function will be assessed using laser speckle contrast imaging (LSCI) in the hand using the flow mediated dilation approach.
The change in skin perfusion is calculated and reported as a fold change from baseline.
|
Baseline, 6 months
|
|
Macrovascular Endothelial Function
Tidsramme: Baseline, 6 months
|
Changes in macrovascular endothelial function will be assessed using sonography during flow mediated dilation approach.
The change in brachial artery diameter is calculated and reported as a %change from baseline.
|
Baseline, 6 months
|
|
Deep Tissue Oxygen Saturation
Tidsramme: Baseline, 6 months
|
Transcutaneous deep tissue oxygen saturation will be measured using the inSpectra near infrared device.
The data are calculated and reported as a %change from baseline.
|
Baseline, 6 months
|
|
Arterial Stiffness
Tidsramme: Baseline, 6 months
|
The arterial stiffness will be measured using the pulse wave analysis approach (SphygmoCor, Atcor medical, Itasca IL, or similar).
Analysis generated the augmentation index which will be used for comparison before and after treatment.
|
Baseline, 6 months
|
|
ECG
Tidsramme: Baseline, 6 months
|
ECG will be recorded for heart rate variability analysis.
The values of high frequency domain, low frequency domain, their ratio, as well as total power will be calculated and used for comparison before and after treatment.
|
Baseline, 6 months
|
|
Glycocalyx - Perfused Boundary Region
Tidsramme: Baseline, 6 months
|
Video recordings of the sublingual vasculature will be performed using the high definition video camera GlycoCheck (Microvascular health solutions).
Data collected will include perfused boundary region (um), and will be used for comparison before and after treatment.
|
Baseline, 6 months
|
|
Capillary Density
Tidsramme: Baseline, 6 months
|
Video recordings of the sublingual vasculature will be performed using the high definition video camera GlycoCheck (Microvascular health solutions).
Data collected will include capillary density (mm/mm^2), and will be used for comparison before and after treatment.
|
Baseline, 6 months
|
|
Red Blood Cell Velocity
Tidsramme: Baseline, 6 months
|
Video recordings of the sublingual vasculature will be performed using the high definition video camera GlycoCheck (Microvascular health solutions).
Data collected will include red blood cell velocity (um/sec), and will be used for comparison before and after treatment.
|
Baseline, 6 months
|
|
Inhibitory Control and Attention
Tidsramme: Baseline, 6 months
|
Flanker Inhibitory Control and Attention Test was used to assess inhibitory control and attention.
The participant is asked to focus on a particular stimulus while inhibiting attention to the stimuli flanking it.
Scores are fully adjusted to nationally representative normative sample of NIH toolbox test takers, accounting for age, sex, race, and education (mean = 50; SD = 10).
Higher scores represent better outcomes.
|
Baseline, 6 months
|
|
Episodic Memory
Tidsramme: Baseline, 6 months
|
Picture Sequence Memory Test was used to assess episodic memory.
Participants are shown a number of activities, and then asked to reproduce the sequence of pictures as it was presented to them.
Scores are fully adjusted to nationally representative normative sample of NIH toolbox test takers, accounting for age, sex, race, and education (mean = 50; SD = 10).
Higher scores represent better outcomes.
|
Baseline, 6 months
|
|
Working Memory
Tidsramme: Baseline, 6 months
|
List Sorting Working Memory Test was used to assess working memory.
The participant is asked to recall and sequence different stimuli that are presented visually and via audio.
Scores are fully adjusted to nationally representative normative sample of NIH toolbox test takers, accounting for age, sex, race, and education (mean = 50; SD = 10).
Higher scores represent better outcomes.
|
Baseline, 6 months
|
|
Language
Tidsramme: Baseline, 6 months
|
Picture Vocabulary Test measures receptive vocabulary administered in a computer-adaptive test (CAT) format.
Respondents select the picture that most closely matches the meaning of the word.
Scores are fully adjusted to nationally representative normative sample of NIH toolbox test takers, accounting for age, sex, race, and education (mean = 50; SD = 10).
Higher scores represent better outcomes.
|
Baseline, 6 months
|
|
Executive Function
Tidsramme: Baseline, 6 months
|
Dimensional Change Card Sort Test was used to assess cognitive flexibility and attention.
The participant is asked to match a series of picture pairs to a target picture.
Scores are fully adjusted to nationally representative normative sample of NIH toolbox test takers, accounting for age, sex, race, and education (mean = 50; SD = 10).
Higher scores represent better outcomes.
|
Baseline, 6 months
|
|
Processing Speed
Tidsramme: Baseline, 6 months
|
Pattern Comparison Processing Speed Test was used to assess processing speed.
Participants are asked to quickly determine whether two stimuli are the same or not the same.
Scores are fully adjusted to nationally representative normative sample of NIH toolbox test takers, accounting for age, sex, race, and education (mean = 50; SD = 10).
Higher scores represent better outcomes.
|
Baseline, 6 months
|
Samarbeidspartnere og etterforskere
Det er her du vil finne personer og organisasjoner som er involvert i denne studien.
Sponsor
Etterforskere
- Hovedetterforsker: Stefano Tarantini, PhD, University of Oklahoma
Studierekorddatoer
Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.
Studer hoveddatoer
Studiestart (Faktiske)
17. november 2022
Primær fullføring (Faktiske)
10. januar 2024
Studiet fullført (Faktiske)
10. januar 2024
Datoer for studieregistrering
Først innsendt
22. juli 2022
Først innsendt som oppfylte QC-kriteriene
2. august 2022
Først lagt ut (Faktiske)
4. august 2022
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
17. august 2026
Siste oppdatering sendt inn som oppfylte QC-kriteriene
25. juni 2026
Sist bekreftet
1. juni 2026
Mer informasjon
Begreper knyttet til denne studien
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- 14856
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
NEI
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Nei
Studerer et amerikansk FDA-regulert enhetsprodukt
Nei
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .